pimavanserin
Selected indexed studies
- Pimavanserin. (, 2012) [PMID:31643450]
- Trial of Pimavanserin in Dementia-Related Psychosis. (N Engl J Med, 2021) [PMID:34289275]
- Pimavanserin. (Drugs Today (Barc), 2015) [PMID:26744739]
_Worker-drafted node — pending editorial review._
Connections
pimavanserin is a side effect of
Sources
- Pimavanserin. (2012) pubmed
- Trial of Pimavanserin in Dementia-Related Psychosis. (2021) pubmed
- Pimavanserin. (2015) pubmed
- Pimavanserin. (2006) pubmed
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. (2014) pubmed
- Pimavanserin in Parkinson's Disease-induced Psychosis: A Literature Review. (2019) pubmed
- Evaluating pimavanserin tartrate as a treatment in Parkinson's disease. (2024) pubmed
- Pimavanserin: Potential Treatment For Dementia-Related Psychosis. (2018) pubmed
- Pimavanserin and Parkinson's Disease Psychosis: A Narrative Review. (2022) pubmed
- Pimavanserin. (2026) pubmed